Stan Lipkowitz

Biochemistry and Molecular Genetics The George Washington University, Washington, DC, United States 
Molecular Biology, Cell Biology
"Stan Lipkowitz"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gatti-Mays ME, Karzai FH, Soltani SN, et al. (2020) A Phase II Single Arm Pilot Study of the CHK1 Inhibitor Prexasertib (LY2606368) in BRCA Wild-Type, Advanced Triple-Negative Breast Cancer. The Oncologist
Daniels SR, Liyasova M, Kales SC, et al. (2019) Loss of function Cbl-c mutations in solid tumors. Plos One. 14: e0219143
Liyasova MS, Ma K, Voeller D, et al. (2019) Cbl interacts with multiple E2s in vitro and in cells. Plos One. 14: e0216967
Botesteanu DA, Lipkowitz S, Lee JM, et al. (2016) Mathematical models of breast and ovarian cancers. Wiley Interdisciplinary Reviews. Systems Biology and Medicine
Yang SX, Polley E, Lipkowitz S. (2016) New insights on PI3K/AKT pathway alterations and clinical outcomes in breast cancer. Cancer Treatment Reviews. 45: 87-96
Dine JL, O'Sullivan CC, Voeller D, et al. (2016) The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl. Breast Cancer Research and Treatment. 155: 235-51
Greer YE, Lipkowitz S. (2016) ONC201: Stressing tumors to death Science Signaling. 9
Li M, Kales SC, Ma K, et al. (2015) Balancing protein stability and activity in cancer: a new approach for identifying driver mutations affecting CBL ubiquitin ligase activation. Cancer Research
Liyasova MS, Ma K, Lipkowitz S. (2015) Molecular pathways: cbl proteins in tumorigenesis and antitumor immunity-opportunities for cancer treatment. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1789-94
Greer YE, Lipkowitz S. (2015) TIC10/ONC201: A bend in the road to clinical development Oncoscience. 2: 75-76
See more...